NASDAQ
PAHC
Last Price
US $32.10
KEY FIGURES
MKT CAP
$1.3B
EPS
TTM
$2.35
PEG
TTM
0.07x
P/E
TTM
13.54x
P/S
TTM
0.99x
YIELD
1.51%
GROWTH
Revenue Y/Y
Profit margin
Current Ratio
Capital Returns
29.49%
Return on equity
ROIC: 11.38%
Valuation History
13.5X
Price to Earnings
EV/EBITDA: 8.9X
Cash flow
Profit margin
10.12%
(FY vs FY)
EBITDA Y/Y
7.65%
(FY vs FY)
Cash flow Y/Y
10.58%
(FY vs FY)
Cash Flow (DCF)
Fair Value
Market $32.10
-96.23%
Default assumptions
EBITDA Multiple
Fair Value
Market $32.10
-74.27%
Default assumptions
Base valuations use default assumptions. Customize in the Valuator.
Valuation
Financial
Performance
Financial risk - Cash flow debt coverage.
Phibro Animal Health Corporation cash flow to debt ratio of 10.52% indicates that the company cannot generate enough cash to cover its debt over time. This level indicates weak financial health.
Financial risk - Healthy cash flow growth.
Phibro Animal Health Corporation's free cash flow has decreased -9.76% from $46.36M last year to $41.83M, signaling decreasing performance
Financial risk - Healthy debt to equity ratio.
Phibro Animal Health Corporation's debt to equity ratio is 2.18, which means that the company's assets are unhealthy financed, signaling financial risk. READ MORE: A ratio over 0.60 means the company finances its assets with debt, signaling financial risk. If ratio is negative, the company spent its own equity and risks bankruptcy
Financial risk - Healthy debt to equity ratio development.
Phibro Animal Health Corporation's debt has increased relative to shareholder equity from 2.05 last year to 2.18 today, signaling weakened financials
Financial risk - Net debt/EBITDA.
Phibro Animal Health Corporation has a net debt to EBITDA ratio of 4.72x, which exceeds the 3.00x threshold, indicating high leverage and potential financial risk
Financial stability - ICR.
Phibro Animal Health Corporation's interest coverage ratio of 4.01 indicates that earnings with good margin can cover interest payments on company debt
Financial stability - Profit margin growth.
Phibro Animal Health Corporation's profit margin has increased (2.57K%) in the last year from 0.24% to 6.35%, signaling increasing performance
Financial stability - Short term assets vs short term liabilities.
Phibro Animal Health Corporation's short-term assets of $810.61M exceed its short-term liabilities of $293.47M
Increasing performance - ROA.
Phibro Animal Health Corporation's return on assets of 6.59% is higher than the 5.00% threshold, indicating efficient asset utilization
Increasing performance - Absolute return on equity.
Phibro Animal Health Corporation's return on equity of 29.49%, is higher than 15.00%, indicating good performance
Increasing performance - Earnings quality.
Phibro Animal Health Corporation's operating cash flow exceeds its net income, indicating high-quality earnings backed by actual cash generation
Increasing performance - Earnings stability.
Phibro Animal Health Corporation had positive net income in 5.00 out of 5 years, indicating stable and consistent earnings
Increasing performance - Free cash flow.
Phibro Animal Health Corporation has positive free cash flow, indicating the company generates cash after capital expenditures
Increasing performance - FCF yield.
Phibro Animal Health Corporation has a free cash flow yield of 3.26%, which is above the 2.00% threshold, indicating strong cash generation relative to market value
Increasing performance - Healthy earnings growth.
Phibro Animal Health Corporation's yearly earnings has increased 1.90K% since last year from $2.42M to $48.26M, signaling increasing performance
Increasing performance - Healthy revenue growth.
Phibro Animal Health Corporation's yearly revenue has increased 27.37% since last year from $1.02G to $1.30G, signaling increasing performance
Increasing performance - ROIC.
ROIC 11.38% (Source: FMP key-metrics). At or above the 10% threshold. Score: 2 of 2. The company is generating returns above the upper end of the typical US weighted-average cost of capital range under this definition of invested capital.
Increasing performance - 3-year revenue CAGR.
Phibro Animal Health Corporation's 3-year revenue CAGR of 11.22% is positive, indicating growing revenue over the past 3 years
Increasing performance - Revenue consistency.
Phibro Animal Health Corporation had revenue growth in 5.00 out of 5 years, indicating consistent revenue performance
Increasing performance - ROE consistency.
Phibro Animal Health Corporation had positive ROE in 5.00 out of 5 years, indicating consistent and reliable returns on equity
Overvalued - DCF valuation.
Phibro Animal Health Corporation is overvalued relative to its fair value price of 1.21 based on Discounted Cash Flow model
Undervalued - Earnings yield.
Phibro Animal Health Corporation has an earnings yield of 7.41%, which is above the 4.00% threshold, indicating the stock offers reasonable value relative to its earnings
Overvalued - EBITDA valuation.
Phibro Animal Health Corporation is overvalued relative to its fair value price of 8.26 based on EBITDA multiple model
Undervalued - EV/EBITDA.
Phibro Animal Health Corporation has an EV/EBITDA ratio of 8.95x, which is below the 20.00x threshold, indicating reasonable valuation relative to its operating earnings
Undervalued - PEG ratio value.
Phibro Animal Health Corporation has a PEG-ratio under 1 which is considered undervalued
Undervalued - P/B ratio.
Phibro Animal Health Corporation has a price-to-book ratio of 3.55x, which is below the 5.00x threshold, indicating reasonable valuation relative to its book value
Undervalued - P/S ratio.
Phibro Animal Health Corporation has a price-to-sales ratio of 0.86x, which is below the 8.00x threshold, indicating reasonable valuation relative to its revenue